Efficacy and Safety of Iberdomide in Patients with Active Systemic Lupus Erythematosus: 24-Week Results of a Phase 2, Randomized, Placebo-Controlled Study

Merrill, Joan T; Werth, Victoria; Furie, Richard; Van, Vollenhoven Ronald; Petronijević, Milan R; Velasco, Zamora Benito; Majdan, Maria; Irazoque-Palazuelos, Fedra; Weiswasser, Michael; Korish, Shimon; Schafer, Peter; Liu, Zhaohui; Gaudy, Allison; Agafonova, Nataliya; Delev, Nikolay

Rezultati

eNauka > Rezultati > Efficacy and Safety of Iberdomide in Patients with Active Systemic Lupus Erythematosus: 24-Week Results of a Phase 2, Randomized, Placebo-Controlled Study

Naziv:	Efficacy and Safety of Iberdomide in Patients with Active Systemic Lupus Erythematosus: 24-Week Results of a Phase 2, Randomized, Placebo-Controlled Study
Autori:	Merrill, Joan T; Werth, Victoria; Furie, Richard; Van, Vollenhoven Ronald; Petronijević, Milan R ; Velasco, Zamora Benito; Majdan, Maria; Irazoque-Palazuelos, Fedra; Weiswasser, Michael; Korish, Shimon; Schafer, Peter; Liu, Zhaohui; Gaudy, Allison; Agafonova, Nataliya; Delev, Nikolay;
Godina:	2020
Publikacija:	ARTHRITIS & RHEUMATOLOGY
ISSN:	2326-5191 Arthritis & Rheumatology Pretraži identifikator
Izdavač:	Wiley
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 72 br. Suppl 10 (Meeting Abstract 0987)
WoS-ID:	000587568502225
URI:	https://enauka.gov.rs/handle/123456789/829796
URL:	https://ezproxy.nb.rs:4257/toc/23265205/2020/72/S10
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
Napomena:	Annual Meeting of the American-College-of-Rheumatology (ACR)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.